◀ Back to RHOA
CTGF — RHOA
Text-mined interactions from Literome
Iwanciw et al., Arterioscler Thromb Vasc Biol 2003
(Fibrosis) :
Specific interference with
RhoA signaling by Y27632 primarily
reduced basal
CTGF expression
Ott et al., J Biol Chem 2003
:
Overexpression of constitutively active
RhoA induced
CTGF synthesis ... Interference with
RhoA signaling by simvastatin, toxinB, C3 toxin, and Y27632
prevented up-regulation of
CTGF
Chowdhury et al., Eur J Biochem 2004
(MAP Kinase Signaling System) :
In particular,
RhoA dependent regulation of the
CTGF/CCN2 gene was concomitant to increased polymerization of actin microfilaments resulting in decreased G- to F-actin ratio and appeared to be achieved at the transcriptional level
Graness et al., Kidney Int 2006
:
On the other hand, when the fibroblasts were cultured on a rigid matrix, that is collagen coated plates, strong focal complexes prevented the dynamic alterations, and
RhoA mediated upregulation of
CTGF expression was independent of Src-FAK signaling
Huang et al., Am J Physiol Lung Cell Mol Physiol 2006
:
Modulation by bradykinin of angiotensin type 1 receptor evoked
RhoA activation of
connective tissue growth factor expression in human lung fibroblasts
Watts et al., Respir Res 2006
(Pulmonary Fibrosis) :
We have previously shown that both
CTGF overexpression and myofibroblast formation in IPF cell lines are
dependent on
RhoA signaling
Crean et al., FASEB J 2006
:
CTGF also
stimulated an increased association between
Rho A and p27 ( Kip-1 )
Muehlich et al., Am J Physiol Cell Physiol 2007
:
Overexpression of constitutively active
RhoA or SRF significantly
increased CTGF protein synthesis
Cicha et al., Atherosclerosis 2008
(Atherosclerosis) :
Pharmacological inhibition of
RhoA signaling
prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress ... In conclusion, non-uniform shear stress dependent
CTGF expression
requires active
RhoA and can be prevented pharmacologically
Black et al., J Biol Chem 2008
:
TGFbeta1 does not stimulate RhoA activation in gingival fibroblasts, and the overexpression of dominant negative
RhoA does not
reduce CCN2/CTGF expression in response to TGFbeta1
Samarin et al., J Biol Chem 2010
:
Activation of
RhoA-Rho kinase signaling by the microtubule disrupting drug combretastatin A4 also
enhanced the DMOG induced
CTGF expression, thus placing CTGF induction by hypoxia in a network of interacting signaling pathways
Iyer et al., Invest Ophthalmol Vis Sci 2012
:
Expression of a constitutively active form of
RhoA ( RhoAV14 ), activation of Rho GTPase by bacterial toxin, or inhibition of Rho kinase by Y-27632 in HTM cells
led to significant but contrasting changes in
CTGF protein levels that were detectable in cell lysates and cell culture medium